189 related articles for article (PubMed ID: 12427041)
1. Structural and functional implications of C-terminal regions of alpha-synuclein.
Kim TD; Paik SR; Yang CH
Biochemistry; 2002 Nov; 41(46):13782-90. PubMed ID: 12427041
[TBL] [Abstract][Full Text] [Related]
2. Distinct roles of the N-terminal-binding domain and the C-terminal-solubilizing domain of alpha-synuclein, a molecular chaperone.
Park SM; Jung HY; Kim TD; Park JH; Yang CH; Kim J
J Biol Chem; 2002 Aug; 277(32):28512-20. PubMed ID: 12032141
[TBL] [Abstract][Full Text] [Related]
3. Stress-induced aggregation profiles of GST-alpha-synuclein fusion proteins: role of the C-terminal acidic tail of alpha-synuclein in protein thermosolubility and stability.
Park SM; Jung HY; Chung KC; Rhim H; Park JH; Kim J
Biochemistry; 2002 Mar; 41(12):4137-46. PubMed ID: 11900557
[TBL] [Abstract][Full Text] [Related]
4. Effects of novel peptides derived from the acidic tail of synuclein (ATS) on the aggregation and stability of fusion proteins.
Park SM; Ahn KJ; Jung HY; Park JH; Kim J
Protein Eng Des Sel; 2004 Mar; 17(3):251-60. PubMed ID: 15067107
[TBL] [Abstract][Full Text] [Related]
5. Structural changes in alpha-synuclein affect its chaperone-like activity in vitro.
Kim TD; Paik SR; Yang CH; Kim J
Protein Sci; 2000 Dec; 9(12):2489-96. PubMed ID: 11206070
[TBL] [Abstract][Full Text] [Related]
6. Degradation of wild-type alpha-synuclein by a molecular chaperone leads to reduced aggregate formation.
Kong B; Chae Y; Lee K
Cell Biochem Funct; 2005; 23(2):125-32. PubMed ID: 15624119
[TBL] [Abstract][Full Text] [Related]
7. Chaperone-like activity of synucleins.
Souza JM; Giasson BI; Lee VM; Ischiropoulos H
FEBS Lett; 2000 May; 474(1):116-9. PubMed ID: 10828462
[TBL] [Abstract][Full Text] [Related]
8. A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human alpha-synuclein.
Du HN; Tang L; Luo XY; Li HT; Hu J; Zhou JW; Hu HY
Biochemistry; 2003 Jul; 42(29):8870-8. PubMed ID: 12873148
[TBL] [Abstract][Full Text] [Related]
9. Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins.
Uversky VN; Li J; Souillac P; Millett IS; Doniach S; Jakes R; Goedert M; Fink AL
J Biol Chem; 2002 Apr; 277(14):11970-8. PubMed ID: 11812782
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein has structural and functional similarities to small heat shock proteins.
Kim TD; Choi E; Rhim H; Paik SR; Yang CH
Biochem Biophys Res Commun; 2004 Nov; 324(4):1352-9. PubMed ID: 15504363
[TBL] [Abstract][Full Text] [Related]
11. The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins.
Rekas A; Ahn KJ; Kim J; Carver JA
Proteins; 2012 May; 80(5):1316-25. PubMed ID: 22274962
[TBL] [Abstract][Full Text] [Related]
12. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
Li HT; Du HN; Tang L; Hu J; Hu HY
Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
[TBL] [Abstract][Full Text] [Related]
13. TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation.
McLean PJ; Kawamata H; Shariff S; Hewett J; Sharma N; Ueda K; Breakefield XO; Hyman BT
J Neurochem; 2002 Nov; 83(4):846-54. PubMed ID: 12421356
[TBL] [Abstract][Full Text] [Related]
14. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.
Li J; Uversky VN; Fink AL
Biochemistry; 2001 Sep; 40(38):11604-13. PubMed ID: 11560511
[TBL] [Abstract][Full Text] [Related]
15. Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases.
Yagi H; Kusaka E; Hongo K; Mizobata T; Kawata Y
J Biol Chem; 2005 Nov; 280(46):38609-16. PubMed ID: 16162499
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70.
Albani D; Peverelli E; Rametta R; Batelli S; Veschini L; Negro A; Forloni G
FASEB J; 2004 Nov; 18(14):1713-5. PubMed ID: 15345691
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein structures from fluorescence energy-transfer kinetics: implications for the role of the protein in Parkinson's disease.
Lee JC; Langen R; Hummel PA; Gray HB; Winkler JR
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16466-71. PubMed ID: 15536128
[TBL] [Abstract][Full Text] [Related]
18. Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain.
Lowe R; Pountney DL; Jensen PH; Gai WP; Voelcker NH
Protein Sci; 2004 Dec; 13(12):3245-52. PubMed ID: 15537754
[TBL] [Abstract][Full Text] [Related]
19. Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein.
Bertoncini CW; Jung YS; Fernandez CO; Hoyer W; Griesinger C; Jovin TM; Zweckstetter M
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1430-5. PubMed ID: 15671169
[TBL] [Abstract][Full Text] [Related]
20. Rapid purification and analysis of alpha-synuclein proteins: C-terminal truncation promotes the conversion of alpha-synuclein into a protease-sensitive form in Escherichia coli.
Choi JY; Sung YM; Park HJ; Hur EH; Lee SJ; Hahn C; Min BR; Kim IK; Kang S; Rhim H
Biotechnol Appl Biochem; 2002 Aug; 36(1):33-40. PubMed ID: 12149120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
